Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CMS opens coverage analysis on oxygen for cluster headaches

This article was originally published in The Gray Sheet

Executive Summary

At the request of the American Headache Society and the American Academy of Neurology, CMS opened a national coverage analysis April 9 on home use of oxygen to treat cluster headaches. Current durable medical equipment policy on home oxygen does not address its use to treat cluster headaches, which CMS says may impact as many as 36,000 Medicare beneficiaries. According to the agency, cluster headaches may occur over many weeks, and are characterized by severe stabbing pain behind the eye, often accompanied by redness and tearing of the eye, as well as nasal congestion. Comments are due May 9

You may also be interested in...



CMS Asked To Offer Distinct Home Oxygen Coverage For Cluster Headache

Neurologists and patient advocates want CMS to update its durable medical equipment policy to cover home oxygen to treat cluster headaches

Long Hot Summer For Novel Drug Reviews Forecast At US FDA

Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.

Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza

The latest drug development news and highlights from our US FDA Performance Tracker.

Topics

UsernamePublicRestriction

Register

MT028719

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel